Trump says he will allow states to import prescription drugs to lower costs

Published 11/22/2019, 03:13 PM
Updated 11/22/2019, 03:16 PM
Trump says he will allow states to import prescription drugs to lower costs

WASHINGTON (Reuters) - U.S. President Donald Trump said on Friday he will soon release a plan to let Florida and other states import prescription medicines to combat high drug prices, and he blasted the Democrat-led House for not going far enough in a drug-pricing bill.

"We will soon be putting more options on the table," Trump wrote in a series of tweets, adding that House Speaker Nancy Pelosi "and her Do Nothing Democrats drug pricing bill doesn’t do the trick."

The tweets were similar to comments the president made on Nov. 15 at a White House event with Health and Human Services (HHS) Secretary Alex Azar, among other officials. At that meeting, Trump said he would work with Florida Governor Ron DeSantis on a plan to broaden rules on importing pharmaceuticals into this country.

Drug companies have staunchly opposed such a plan, which has been mulled for years but never implemented.

"House Republicans are showing real LEADERSHIP and prepared to enact bipartisan solutions for drug prices. Do Nothing Democrats are playing partisan politics with YOUR drug prices! We are READY to work together if they actually want to get something done!," the president, who faces impeachment by the Democrat-led House of Representatives, said on Twitter.

U.S. prescription drug costs are the highest in the developed world because most other countries negotiate pricing directly with manufacturers, while drug companies are allowed to set their own prices in the United States.

Lowering healthcare costs for U.S. consumers is expected to be a major issue in the 2020 presidential campaign.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.